The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

Skip to main content

Breast Tomosynthesis (3D) Integrated with MRI

Multimodal imaging with digital breast tomosynthesis and contrast-enhanced MRI in problem-solving

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Radyoloji department. Book Appointment →

What is Breast Tomosynthesis (3D) Integrated with MRI?

Digital breast tomosynthesis (DBT) is a tomographic imaging modality that acquires 1 mm thin section reconstructions of the breast through the rotation of the X-ray tube; it overcomes the tissue overlap limitation of conventional 2D mammography. Studies have shown that DBT improves invasive cancer detection in dense breasts by 27% and reduces false-positive recall rates by 15-30%.

Contrast-enhanced breast MRI is the most sensitive imaging modality for invasive cancer (sensitivity 90-95%); it employs T1-weighted dynamic and DWI sequences. It is recommended for high-risk patients (BRCA1/2 carriers, history of chest radiation), tumor extent evaluation in newly diagnosed cancer, and discordant cases.

Integrated DBT-MRI use is preferred in BI-RADS 4 lesions, screening of high-risk patients, and pre-neoadjuvant chemotherapy planning. Selection of biopsy guidance modality depends on lesion characteristics.

Symptoms

Palpable breast mass
Mammographic dense breast finding (heterogeneously dense or extremely dense)
BI-RADS 4 lesion follow-up
Family history (BRCA1/2)
Bloody nipple discharge
Concordance evaluation in newly diagnosed cancer

Risk Factors

BRCA1/BRCA2 mutation
Personal history of breast cancer
Family history (1st degree relative)
Lifetime risk over 20% (Gail model)
Chest radiation history (Hodgkin lymphoma)
Lobular carcinoma in situ (LCIS)

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Newly detected breast mass
  • Bloody nipple discharge
  • Skin retraction or peau d'orange
  • BI-RADS 4-5 finding on mammography
  • High-risk patient (annual screening time)

Treatment Methods

01
DBT screening (every 1-2 years; in dense breasts)
02
Contrast-enhanced MRI (in high-risk patients, annual)
03
Targeted ultrasound (after MRI-detected lesion)
04
MRI-guided biopsy (vacuum-assisted biopsy)
05
Stereotactic DBT-guided biopsy
06
Surgical localization (wire/Magseed)

Which Department to Visit?

You can visit our Radyoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Radyoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.